The 60,000 sq. ft. expansion will include an isolated 20,000 sq. ft. “Clean Compounding” room that will house up to six new compounding lines. This clean environment, coupled with Americhem’s already existing ISO 13485 Certification, Formulation Control, Change Management Procedures and Regulatory Support Documentation, gives Americhem Engineered Compounds unique capabilities to produce compounds that meet the most stringent Medical Device requirements. A new Customer Center is also included in the expansion to facilitate technical meetings.
“We continue to see significant opportunities to grow our existing segments and diversify into new segments.” stated Jim Figaniak, Vice President & General Manager of Americhem Engineered Compounds. “Americhem Engineered Compounds has become a polymeric solution providing leader in the medical industry over the past few years. To continue supporting this growth, our current customers, and influx of new customers, a plant expansion was the next strategic move to make.”
